Amy E. Mckee serves as Executive at BIOCRYST PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Amy E. Mckee has executed 6 insider transactions totaling $54.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 28, 2025 involved receiving (via award) 783 shares valued at $5.6K.
Amy E. Mckee currently holds 41,790 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy E. Mckee has been a net seller of BCRX stock. They have purchased $0 and sold $54.4K worth of shares.
Amy E. Mckee's most recent insider trade was on Nov 28, 2025, when they sold 783 shares at $7.18 per share.
Get notified when new Form 4 filings are submitted
| $8.31 |
| Discretionary |
| Jun 24, 2024 | BCRX | $54.4K | Sale | 8,600 | $6.32 | Discretionary |
| Jun 12, 2024 | BCRX | $0 | Award | 6,820 | $N/A | Discretionary |
| Jun 13, 2023 | BCRX | $0 | Award | 16,745 | $N/A | Discretionary |
| Jun 7, 2022 | BCRX | $0 | Award | 12,866 | $N/A | Discretionary |